Research Interests 

• Role of expectations in mental and physical illnesses
• Placebo and nocebo effects
• Perception and coping with physical complaints
• Somatoform disorders, somatic stress disorder

Curriculum Vitae

• Inhalt ausklappen Inhalt einklappen Education

  1978-1979
  Physics, University of Karlsruhe, Germany
  
  1979-1984
  Psychology, University of Trier, Germany
  Degree : Diploma in Psychologie (Dipl.-Psych.)
  
  1987 
  University of Konstanz; Dr.rer.soc; Supervisor: Prof. Dr. R. Cohen
  Title of Ph.D. thesis: Visual Information Processing in Chronic Schizophrenics ( a EEG-based study)
  
  1994
  University of Salzburg (Prof. Dr. Urs Baumann); Title: Somatoform Disorders: Multiple somatoform symptoms and hypochondriasis

• Inhalt ausklappen Inhalt einklappen Professional Experience

  Academic appointments
  
  07/1981 - 06/1982
  Student Assistant in the team of Prof. Dr. Bartussek, University of Trier , Personality Psychology
  
  07/1982 - 10/1984
  Student Assistant in the team of Prof. Dr. R. Ferstl, University of Trier, Clinical Psychology and Psychophysiology
  
  11/1984 - 12/1985
  Assistant in the team of Prof. Dr. R. Cohen, University of Konstanz / Psychiatric Hospital Reichenau, Topics: Clinical Psychology, Psychophysiology; Schizophrenia Research
  
  1991/1992 – 2000
  Lecturer at the University of Salzburg
  
  01/2001 - present
  Professor of Clinical Psychology and Psychotherapy (Chair); University of Marburg
  
  
  Clinical Appointments
  
  01/1986 - 09/1987
  Psychologist, Psychiatric Hospital, Krankenhaus Rottenmünster, Rottweil 
  
  10/1987 - 01/1989
  Psychologist, Psychosomatic Hospital Roseneck. Topics: Eating Disorders, Anxiety Disorders, Somatoform Disorders
  
  02/1989 - 02/2000
  Head of the Psychology Department Roseneck Hospital (affiliated with the Medical Faculty of the University of Munich)
  
  2001 – present
  Head of the Outpatient Clinic for Psychological Interventions, University of Marburg, Germany; Head of the postgraduate training program in cognitive-behavior therapy

• Inhalt ausklappen Inhalt einklappen Stays Abroad and Awards

  Auckland, New Zealand: Auszeichnung und Einladung als ASB Visiting Professor of the Medical School, University of Auckland, NZ (September – Oktober 2002)

  Harvard University/Harvard Medical School, Boston/Cambridge, USA: Invited Guest Professor, Department of Psychiatric Research, Brigham and Women’s Hospital / Prof.Dr.A. Barsky; 09/2004-01/2005.

  University of California San Diego, Medical School; Einladung von Prof. Dr. J. Dimsdale, M.D., Gastprofessor an der UCSD von 09/2009-01/2010

  Winterthur, 2004: Award of excellent scientific contribution; Biofeedback Foundation of Europe

  Ernennung als Mitglied des Sachverständigenrates für medizinische und pharmazeutische Prüfungsfragen IMPP 01/2006-12/2009

  Ausgewählt zu „Deutschland’s Top Medizinern“ in den Bereichen „Experte für Depression und bipolare Störungen“ und „Experte für Angststörungen“; FOCUS Ärzteliste seit 2011 bis a.w..

  Invited Expert; Expert Conference on „Somatic Presentations of Mental Disorders“ in Bejing (Task: Preparation of classification criteria for ICD-11 and DSM-V); under the auspices of the American Psychiatric Association APA, the National Institute of Health NIH, and the World Health Organization WHO 04/2006

  Co-chair of IASP Task Force on “Chronic Pain Diagnoses in ICD-11”, seit 2012.

  DFG-Fachkollegiat, 11/2011 – 03/2020; Mitglied der DFG-Kommission “Klinische Studien”.

  Distinguished International Affiliate, APA Div. „Health Psychology“

  Distinguished Scientist, ISBM (International Society of Behavioral Medicine), 2014

Publications

• Inhalt ausklappen Inhalt einklappen Selected Publications

  1.       ** Petrie, K.J. & Rief, W. (2019). Psychobiological mechanisms of placebo and nocebo effects: Pathways to improve treatments and reduce side effects. Annual Review of Psychology, 70, 12.1–12.27. IF 20.

  2.       ** Rief, W., Bleichhardt, G., Dannehl, K., Euteneuer, F., & Wambach, K. (2018). Comparing the efficacy of CBASP with two versions of CBT for depression in a routine care center: A randomized clinical trial. Psychotherapy and Psychosomatics (IF 8.9)

  3.       * Glombiewski, J.A., Jeroen, J., Vlaeyen, J., Riecke, J., Holzapfel, S. & Rief, W. (2018). Exposure and CBT for chronic back pain: an RCT on differential efficacy and optimal length of treatment. Journal of Consulting and Clinical Psychology, 86, 533-545.

  4.       * Henningsen, P., Gundel, H., Kop, W. J., Lowe, B., Martin, A., Rief, W., Rosmalen, J. G. M., Schroder, A., van der Feltz-Cornelis, C., Van den Bergh, O., & Grp, Euronet-Soma. (2018). Persistent Physical Symptoms as Perceptual Dysregulation: A Neuropsychobehavioral Model and Its Clinical Implications. Psychosomatic Medicine, 80(5), 422-431. doi: 10.1097/psy.0000000000000588

  5.       ** Rief, W., Shedden Mora, M., Laferton, J., Auer, C., Petrie, K.J., Salzmann, S., Schedlowski, M.& Moosdorf, R.(2017). Preoperative optimization of patient expectations improves long-term outcome in heart surgery patients: Results of the randomized controlled PSY-HEART trial. BMC Medicine, 15:4. IF 8.0.

  6.      * Rief, W., Burton, C., Frostholm, L., Henningsen, P., Kleinstäuber, M., Kop, W.J., Löwe, B., Martin, A., Malt, U., Rosmalen, J., Schröder, A., Shedden-Mora, M., Toussaint, A., van der Feltz-Cornelis, C. on behalf of the EURONET-SOMA Group. Core outcome domains for clinical trials on somatic symptom disorder, bodily distress disorder and functional somatic syndromes: EURONET-SOMA recommendations. Psychosomatic Medicine 79, 1008-1015.

  7.       ** Rief, W., & Glombiewski, J. A. (2017). The role of expectations in mental disorders and their treatment. World Psychiatry, 16(2), 210-211. doi: 10.1002/wps.20427 (IF 20).

  8.       * Rheker, J., Winkler, A., Doering, B. & Rief, W.(2017). Learning to experience side effects after antidepressant intake – Results from a randomized, controlled, double-blind study. Psychopharmacology, 234, 329-338.

  9.       ** Rief, W., Barsky, A. J., Bingel, U., Doering, B., Schwarting, R., Wöhr, M., & Schweiger, U. (2016). Rethinking psychopharmacotherapy: The role of treatment context and brain plasticity in antidepressant and antipsychotic interventions. Neuroscience & Biobehavioral Reviews 60, 51-64. doi: http://dx.doi.org/10.1016/j.neubiorev.2015.11.008. IF 8.8.

  10.   ** Schedlowski, M., Enck, P., Rief, W.& Bingel, U. (2015). Neuro-Bio-Behavioral Mechanisms of Placebo and Nocebo Responses: Implications for Clinical Trials and Clinical Practice. Pharmacological Review 67, 697–730.(IF 20)

  11.   ** Treede, R.-D., Rief, W., Barke, A., Aziz, Q., Bennett, M.I., Benoliel, R., Cohen, M., Evers, S., Finnerup, N.B., First, M.B., Giamberardino, M.A., Kaasa, S., Kosek, E., Lavandʼhomme, P., Nicholas, M., Perrot, S., Scholz, J., Schug, S., Smith, B.H., Svensson, P., Vlaeyen, J.W.S., Wang, S.-J. (2015). A classification of chronic pain for ICD-11. Pain 156(6): 1003-7. (IF 5.8)

  12.   ** Rief, W.& Martin, A. (2014). How to use the new DSM-5 diagnosis Somatic Symptom Disorder in research and practice? – A critical evaluation and a proposal for modifications. Annual Review of Clinical Psychology 10, 339–67. IF 12.4.

  13.   ** Bingel, U.(for the Placebo Competence Group: U. Bingel, P. Enck, W. Rief, M. Schedlowski) (2014). Avoiding nocebo effects to optimize treatment outcome. JAMA, 312, 693-694 (IF 30).

  14.   ** Enck, P., Bingel, U., Schedlowski, M.& Rief, W.(2013). Minimize, maximize, or personalize? – What to do with the placebo response in medicine? Nature Review Drug Discovery, Vol. 12, 191-204. (IF 47).(Shared authorship of all authors)

  15.   ** Glombiewski, J.A.& Rief, W. (2013). Nonadherence to medication. JAMA, 310, 1505-1506. (letter). IF 30.0

  16.   ** Rief, W. & Glombiewski, J.A. (2012). The hidden effects of blinded, placebo controlled randomized trials: An experimental investigation. Pain 153, 2473-2477.(IF 5.8)

  17.   * Lincoln, T., Lüllmann, E., Mehl, S., Ziegler, M., Rief, W.(2012). Moving from efficacy to effectiveness in cognitive behavioural therapy for psychosis: A randomized clinical-practice trial. Journal of Consulting and Clinical Psychology 80, 674-686.

  18.   **Rief, W., Bingel, U., Schedlowski, M. & Enck, P.(2011). Mechanisms involved in placebo and nocebo responses and implications for drug trials. Clinical Pharmacology & Therapeutics 90, 722-726 (IF 6.7).
   

• Inhalt ausklappen Inhalt einklappen pdf-Download of all  Publications (11/22)

  Publications - Winfried Rief